von König CH |
Use of antibiotics in the prevention and treatment of pertussis. |
2005 |
Pediatr. Infect. Dis. J. |
pmid:15876929
|
Syrogiannopoulos GA et al. |
High prevalence of erythromycin resistance of Streptococcus pyogenes in Greek children. |
2001 |
Pediatr. Infect. Dis. J. |
pmid:11734765
|
Petersen JP et al. |
Community outbreak of perianal group A streptococcal infection in Denmark. |
2003 |
Pediatr. Infect. Dis. J. |
pmid:12586971
|
Block S et al. |
Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. |
1995 |
Pediatr. Infect. Dis. J. |
pmid:7667050
|
Lopes AI et al. |
Antibiotic-resistant Helicobacter pylori strains in Portuguese children. |
2005 |
Pediatr. Infect. Dis. J. |
pmid:15876938
|
Yang YJ et al. |
Prevalence and rapid identification of clarithromycin-resistant Helicobacter pylori isolates in children. |
2001 |
Pediatr. Infect. Dis. J. |
pmid:11465837
|
Hardy DJ |
Extent and spectrum of the antimicrobial activity of clarithromycin. |
1993 |
Pediatr. Infect. Dis. J. |
pmid:8295818
|
Reid R et al. |
Pneumococcal meningitis during therapy of otitis media with clarithromycin. |
1995 |
Pediatr. Infect. Dis. J. |
pmid:8786899
|
Chaturvedi S et al. |
Hemolytic uremic syndrome caused by Bordetella pertussis infection. |
2010 |
Pediatr. Nephrol. |
pmid:20145955
|
Galarza M et al. |
Pediatric granulomatous cerebral amebiasis: a delayed diagnosis. |
2002 |
Pediatr. Neurol. |
pmid:11897483
|
Glatstein M et al. |
Lung abscess due to non-tuberculous, non-Mycobacterium fortuitum in a neonate. |
2012 |
Pediatr. Pulmonol. |
pmid:22451300
|
Colin AA and Ali-Dinar T |
Aerosolized amikacin and oral clarithromycin to eradicate Mycobacterium abscessus in a patient with cystic fibrosis: an 8-year follow-up. |
2010 |
Pediatr. Pulmonol. |
pmid:20503290
|
Liu X et al. |
High macrolide resistance in Streptococcus pyogenes strains isolated from children with pharyngitis in China. |
2009 |
Pediatr. Pulmonol. |
pmid:19360846
|
Iwanaga K and Carter ER |
Mycobacterium abscessus complex lung infection in a toddler with a tracheostomy. |
2014 |
Pediatr. Pulmonol. |
pmid:23460506
|
Ordoñez CL et al. |
Effect of clarithromycin on airway obstruction and inflammatory markers in induced sputum in cystic fibrosis: a pilot study. |
2001 |
Pediatr. Pulmonol. |
pmid:11416873
|
Robinson P et al. |
Clarithromycin therapy for patients with cystic fibrosis: a randomized controlled trial. |
2012 |
Pediatr. Pulmonol. |
pmid:22266895
|
Bitzan M et al. |
Rituximab (B-cell depleting antibody) associated lung injury (RALI): a pediatric case and systematic review of the literature. |
2009 |
Pediatr. Pulmonol. |
pmid:19681063
|
Kurz H et al. |
Role of Chlamydophila pneumoniae in children hospitalized for community-acquired pneumonia in Vienna, Austria. |
2009 |
Pediatr. Pulmonol. |
pmid:19670403
|
Colin AA |
Eradication of mycobacterium abscessus in a chronically infected patient with cystic fibrosis. |
2000 |
Pediatr. Pulmonol. |
pmid:10973047
|
Kato S et al. |
Omeprazole-based dual and triple regimens for Helicobacter pylori eradication in children. |
1997 |
Pediatrics |
pmid:9200377
|
Madadi P et al. |
Fatal hydrocodone overdose in a child: pharmacogenetics and drug interactions. |
2010 |
Pediatrics |
pmid:20837591
|
Bitnun A et al. |
Children hospitalized with severe acute respiratory syndrome-related illness in Toronto. |
2003 |
Pediatrics |
pmid:14523209
|
Broussard CS et al. |
Exposure to antibiotics in a United States-Mexico border birth cohort. |
2010 |
Pediatrics |
pmid:20457685
|
Ozdemir R et al. |
Clarithromycin in preventing bronchopulmonary dysplasia in Ureaplasma urealyticum-positive preterm infants. |
2011 |
Pediatrics |
pmid:22123897
|
Moshkowitz M et al. |
One-week triple therapy with omeprazole, clarithromycin, and nitroimidazole for Helicobacter pylori infection in children and adolescents. |
1998 |
Pediatrics |
pmid:9651466
|
Giacometti A et al. |
Combination studies between polycationic peptides and clinically used antibiotics against Gram-positive and Gram-negative bacteria. |
2000 |
Peptides |
pmid:11035200
|
Giacometti A et al. |
In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection. |
2005 |
Peptides |
pmid:16269345
|
Giacometti A et al. |
In vitro effect of short-term exposure to two synthetic peptides, alone or in combination with clarithromycin or rifabutin, on Cryptosporidium parvum infectivity. |
2002 |
Peptides |
pmid:12084535
|
Tse KC et al. |
Delusion of worm infestation associated with clarithromycin in a patient on peritoneal dialysis. |
2001 Jul-Aug |
Perit Dial Int |
pmid:11587409
|
Curry EM et al. |
CAPD peritonitis caused by Mycobacterium rhodesiae. |
2008 Jan-Feb |
Perit Dial Int |
pmid:18178955
|
Verbanck JJ et al. |
Campylobacter jejuni II peritonitis in a CCPD patient: cure by oral clarithromycin. |
1999 Jan-Feb |
Perit Dial Int |
pmid:10201350
|
Kazama I and Maruyama Y |
Differential effects of clarithromycin and azithromycin on delayed rectifier K(+)-channel currents in murine thymocytes. |
2013 |
Pharm Biol |
pmid:23527897
|
Hassan ST et al. |
In vitro synergistic effect of Hibiscus sabdariffa aqueous extract in combination with standard antibiotics against Helicobacter pylori clinical isolates. |
2016 |
Pharm Biol |
pmid:26731378
|
Shahbazi Niaz M et al. |
Investigation into physical-chemical variables affecting the manufacture and dissolution of wet-milled clarithromycin nanoparticles. |
2014 |
Pharm Dev Technol |
pmid:24093825
|
Alkhalidi BA et al. |
Development of a predictive in vitro dissolution for clarithromycin granular suspension based on in vitro-in vivo correlations. |
2010 |
Pharm Dev Technol |
pmid:22716469
|
Matuz M et al. |
Non-prescription antibiotic use in Hungary. |
2007 |
Pharm World Sci |
pmid:17530434
|
Becker ML et al. |
Determinants of potential drug-drug interaction associated dispensing in community pharmacies in the Netherlands. |
2007 |
Pharm World Sci |
pmid:17187223
|
Sancar M et al. |
Pharmacoeconomic comparison of Helicobacter pylori eradication regimens. |
2006 |
Pharm World Sci |
pmid:17066247
|
Ufuk A et al. |
In Vitro Assessment of Uptake and Lysosomal Sequestration of Respiratory Drugs in Alveolar Macrophage Cell Line NR8383. |
2015 |
Pharm. Res. |
pmid:26224396
|
Dimer F et al. |
Inhalable Clarithromycin Microparticles for Treatment of Respiratory Infections. |
2015 |
Pharm. Res. |
pmid:26113237
|
Vehring R |
Pharmaceutical particle engineering via spray drying. |
2008 |
Pharm. Res. |
pmid:18040761
|
Kita T et al. |
CYP2C19 genotype related effect of omeprazole on intragastric pH and antimicrobial stability. |
2001 |
Pharm. Res. |
pmid:11465416
|
Haghi M et al. |
Immunomodulatory effects of a low-dose clarithromycin-based macrolide solution pressurised metered dose inhaler. |
2015 |
Pharm. Res. |
pmid:25537341
|
Lu MY et al. |
A polymer carrier system for taste masking of macrolide antibiotics. |
1991 |
Pharm. Res. |
pmid:1829521
|
Rotsch TD et al. |
Determination of clarithromycin as a contaminant on surfaces by high-performance liquid chromatography using electrochemical detection. |
1991 |
Pharm. Res. |
pmid:1833731
|
Meng Y et al. |
Multi-functional Liposomes Enhancing Target and Antibacterial Immunity for Antimicrobial and Anti-Biofilm Against Methicillin-Resistant Staphylococcus aureus. |
2016 |
Pharm. Res. |
pmid:26666773
|
Takeuchi T et al. |
Establishment and characterization of the transformants stably-expressing MDR1 derived from various animal species in LLC-PK1. |
2006 |
Pharm. Res. |
pmid:16779700
|
Rose WE et al. |
Prevention of biofilm formation by methacrylate-based copolymer films loaded with rifampin, clarithromycin, doxycycline alone or in combination. |
2015 |
Pharm. Res. |
pmid:24934663
|
Craig AM et al. |
Decision analysis of Helicobacter pylori eradication therapy using omeprazole with either clarithromycin or amoxicillin. |
1996 |
Pharmacoeconomics |
pmid:10160472
|
Agro K et al. |
Cost effectiveness in Canada of a multidrug prepackaged regimen (Hp-PAC)+ for Helicobacter pylori eradication. |
2001 |
Pharmacoeconomics |
pmid:11596835
|
Plosker GL and Figgitt DP |
Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus. |
2004 |
Pharmacoeconomics |
pmid:15099124
|
Allen LaPointe NM et al. |
Frequency of high-risk use of QT-prolonging medications. |
2006 |
Pharmacoepidemiol Drug Saf |
pmid:16178046
|
Quach C et al. |
Effectiveness of amoxicillin, azithromycin, cefprozil and clarithromycin in the treatment of acute otitis media in children: a population-based study. |
2005 |
Pharmacoepidemiol Drug Saf |
pmid:15386697
|
Galatti L et al. |
Co-prescriptions with itraconazole and fluconazole as a signal for possible risk of drug-drug interactions: a four-year analysis from Italian general practice. |
2007 |
Pharmacoepidemiol Drug Saf |
pmid:17323404
|
Corrao G et al. |
Generating signals of drug-adverse effects from prescription databases and application to the risk of arrhythmia associated with antibacterials. |
2005 |
Pharmacoepidemiol Drug Saf |
pmid:15390219
|
Drinkard CR et al. |
Postmarketing surveillance of medications and pregnancy outcomes: clarithromycin and birth malformations. |
2000 |
Pharmacoepidemiol Drug Saf |
pmid:11338912
|
Bérard A et al. |
Use of macrolides during pregnancy and the risk of birth defects: a population-based study. |
2015 |
Pharmacoepidemiol Drug Saf |
pmid:26513406
|
Fohner AE et al. |
PharmGKB summary: Macrolide antibiotic pathway, pharmacokinetics/pharmacodynamics. |
2017 |
Pharmacogenet. Genomics |
pmid:28146011
|
Karczewska E et al. |
Primary and secondary clarithromycin, metronidazole, amoxicillin and levofloxacin resistance to Helicobacter pylori in southern Poland. |
2011 |
Pharmacol Rep |
pmid:21857091
|
Szałek E et al. |
Sunitinib in combination with clarithromycin or azithromycin - is there a risk of interaction or not? |
2012 |
Pharmacol Rep |
pmid:23406766
|
Yamamoto K et al. |
Clarithromycin prevents human respiratory syncytial virus-induced airway epithelial responses by modulating activation of interferon regulatory factor-3. |
2016 |
Pharmacol. Res. |
pmid:27468646
|
Calabresi L et al. |
Pharmacokinetic interactions between omeprazole/pantoprazole and clarithromycin in health volunteers. |
2004 |
Pharmacol. Res. |
pmid:14998561
|
Pauwels O |
Factors contributing to carbamazepine-macrolide interactions. |
2002 |
Pharmacol. Res. |
pmid:12030792
|
Woo PC et al. |
Clarithromycin attenuates cyclophosphamide-induced mucositis in mice. |
2000 |
Pharmacol. Res. |
pmid:10753551
|
Marjanović N et al. |
Macrolide antibiotics broadly and distinctively inhibit cytokine and chemokine production by COPD sputum cells in vitro. |
2011 |
Pharmacol. Res. |
pmid:21315154
|
Woo PC et al. |
Clarithromycin attenuates the inflammatory response induced by surgical trauma in a guinea pig model. |
1999 |
Pharmacol. Res. |
pmid:10051377
|
Jokinen MJ et al. |
Effect of clarithromycin and itraconazole on the pharmacokinetics of ropivacaine. |
2001 |
Pharmacol. Toxicol. |
pmid:11322176
|
Kitano M et al. |
Effects of clarithromycin and dexamethasone on mucus production in isografted rat trachea. |
2011 |
Pharmacology |
pmid:21228611
|
Schulz-Du Bois C et al. |
Major increase of quetiapine steady-state plasma concentration following co-administration of clarithromycin: confirmation of the pharmacokinetic interaction potential of quetiapine. |
2008 |
Pharmacopsychiatry |
pmid:19067264
|
Najib MM et al. |
Cost-effectiveness of sparfloxacin compared with other oral antimicrobials in outpatient treatment of community-acquired pneumonia. |
2000 |
Pharmacotherapy |
pmid:10772376
|
Mertl SL |
The role of clarithromycin in the prophylaxis of disseminated Mycobacterium avium-intracellulare infection in patients with AIDS. |
1996 May-Jun |
Pharmacotherapy |
pmid:8726597
|
Mor N et al. |
Accumulation of clarithromycin in macrophages infected with Mycobacterium avium. |
1994 Jan-Feb |
Pharmacotherapy |
pmid:8159593
|
Auclair B et al. |
Potential interaction between itraconazole and clarithromycin. |
1999 |
Pharmacotherapy |
pmid:10600094
|
Khamaisi M and Leitersdorf E |
Severe hypoglycemia from clarithromycin-repaglinide drug interaction. |
2008 |
Pharmacotherapy |
pmid:18447665
|
Otsuka SH |
Severe hypoglycemia from Helicobacter pylori triple-drug therapy and insulin detemir drug interaction. |
2013 |
Pharmacotherapy |
pmid:23471710
|
Nicholson SC et al. |
Antimicrobial-associated acute hepatitis. |
2002 |
Pharmacotherapy |
pmid:12066973
|
Gaylor AS and Reilly JC |
Therapy with macrolides in patients with cystic fibrosis. |
2002 |
Pharmacotherapy |
pmid:11837560
|
Adelglass J et al. |
A multicenter, investigator-blinded, randomized comparison of oral levofloxacin and oral clarithromycin in the treatment of acute bacterial sinusitis. |
1998 Nov-Dec |
Pharmacotherapy |
pmid:9855324
|
Kang-Birken SL and Prichard JG |
Mycobacterium szulgai in a patient with advanced acquired immunodeficiency syndrome: an unusual pathogen with unusual multidrug resistance. |
2006 |
Pharmacotherapy |
pmid:17064210
|
Guerriero SE et al. |
Two cases of clarithromycin-induced digoxin toxicity. |
1997 Sep-Oct |
Pharmacotherapy |
pmid:9324195
|
McConnell SA and Amsden GW |
Review and comparison of advanced-generation macrolides clarithromycin and dirithromycin. |
1999 |
Pharmacotherapy |
pmid:10212011
|
Molden E and Andersson KS |
Simvastatin-associated rhabdomyolysis after coadministration of macrolide antibiotics in two patients. |
2007 |
Pharmacotherapy |
pmid:17381388
|
Oberg KC |
Delayed elevation of international normalized ratio with concurrent clarithromycin and warfarin therapy. |
1998 Mar-Apr |
Pharmacotherapy |
pmid:9545160
|
Shin J et al. |
Effect of cytochrome P450 3A5 genotype on atorvastatin pharmacokinetics and its interaction with clarithromycin. |
2011 |
Pharmacotherapy |
pmid:21950641
|
Stein GE et al. |
A preliminary study of clarithromycin versus doxycycline in the treatment of nongonococcal urethritis and mucopurulent cervicitis. |
1995 Nov-Dec |
Pharmacotherapy |
pmid:8602379
|
Stein GE and Schooley S |
Serum bactericidal activity of extended-release clarithromycin against macrolide-resistant strains of Streptococcus pneumoniae. |
2002 |
Pharmacotherapy |
pmid:12013358
|
Sketris IS et al. |
Possible role of the intestinal P-450 enzyme system in a cyclosporine-clarithromycin interaction. |
1996 Mar-Apr |
Pharmacotherapy |
pmid:8820476
|
Legendre DP et al. |
Hansen's disease (Leprosy): current and future pharmacotherapy and treatment of disease-related immunologic reactions. |
2012 |
Pharmacotherapy |
pmid:22392826
|
Guo D et al. |
The cardiotoxicity of macrolides: a systematic review. |
2010 |
Pharmazie |
pmid:21038838
|
Valizadeh H et al. |
Antibacterial activity of clarithromycin loaded PLGA nanoparticles. |
2012 |
Pharmazie |
pmid:22393833
|
Togami K et al. |
Transport characteristics of clarithromycin, azithromycin and telithromycin, antibiotics applied for treatment of respiratory infections, in Calu-3 cell monolayers as model lung epithelial cells. |
2012 |
Pharmazie |
pmid:22764569
|
Hamdan II |
Comparative in vitro investigations of the interaction between some macrolides and Cu(II), Zn(II) and Fe(II). |
2003 |
Pharmazie |
pmid:12685822
|
Lohitnavy M et al. |
Pharmacokinetic and bloequivalence studies of generic clarithromycin tablets in healthy male volunteers. |
2003 |
Pharmazie |
pmid:12622260
|
Chadha R et al. |
Quantitative analysis of in vitro compatibility of binary and ternary mixtures of nitroimidazole and macrolides in combination with omeprazole using a calorimetric technique. |
2007 |
Pharmazie |
pmid:17557738
|
Kim PK and Dorshimer GW |
Case report: peptic ulcer disease in a professional athlete. |
2009 |
Phys Sportsmed |
pmid:20048520
|
Celik H and Ayar A |
Clarithromycin inhibits myometrial contractions in isolated human myometrium independent of stimulus. |
2002 |
Physiol Res |
pmid:12234115
|
Stege PW et al. |
Antimicrobial activity of aqueous extracts of Larrea divaricata Cav (jarilla) against Helicobacter pylori. |
2006 |
Phytomedicine |
pmid:17085295
|
Dabos KJ et al. |
The effect of mastic gum on Helicobacter pylori: a randomized pilot study. |
2010 |
Phytomedicine |
pmid:19879118
|
Nostro A et al. |
Effects of combining extracts (from propolis or Zingiber officinale) with clarithromycin on Helicobacter pylori. |
2006 |
Phytother Res |
pmid:16521108
|
Lawal TO et al. |
Combination studies of Eucalyptus torelliana F. Muell. leaf extracts and clarithromycin on Helicobacter pylori. |
2012 |
Phytother Res |
pmid:22318891
|